CD93 and systemic sclerosis: We suggest that CD93 and SFRP4 may play a pivotal role in the developing of SSc and may serve as biomarkers for diagnosis, which may be beneficial in controlling autophagy levels and making appropriate diagnosis and treatment decisions for patients.